Source:

Press Release

November 22, 2020
1 min read
Save

Embody receives FDA clearance for bioengineered collagen-based implant

Source:

Press Release

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Embody Inc. has received FDA 510(k) clearance for its T biointegrative implant for tendon and ligament repair, according to a press release.

Utilizing a proprietary micro-architecture, the T implant is specifically designed for soft tissue injuries, which accounted for 2.4 million surgeries in the US in 2019, according to the release.

“This FDA clearance represents a major milestone in the advancement of Embodys mission to improve outcomes for patients who suffer from tendon and ligament injuries,” Jeff Conroy, CEO of Embody, said in the release. “We believe T represents a significant advancement in collagen science and provides surgeons with a compelling solution with broad clinical utility for tendon repair procedures,” he added.